These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4037772)

  • 21. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.
    Goldwater PN
    Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cerebrospinal fluid diffusion kinetics of cefotaxime and fosfomycin in Staphylococcus aureus meningitis with otorrhea].
    Tremeaux JC; Portier H; Sautreaux JL; Pechinot A; Kazmierczak A
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):556-8. PubMed ID: 6087251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis.
    Humbert G; Leroy A; Nair SR; Cherubin CE
    J Antimicrob Chemother; 1984 May; 13(5):487-94. PubMed ID: 6330021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefotaxime vs. conventional therapy for the treatment of bacterial meningitis of infants and children.
    Odio CM; Faingezicht I; Salas JL; Guevara J; Mohs E; McCracken GH
    Pediatr Infect Dis; 1986; 5(4):402-7. PubMed ID: 3725653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Transferability of cefodizime to cerebrospinal fluid of rabbits with meningitis caused by Staphylococcus aureus].
    Haruta T; Okura K; Kuroki S; Yamamoto H; Kobayashi Y
    Jpn J Antibiot; 1989 Jun; 42(6):1279-85. PubMed ID: 2795852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.
    Odio CM; Faingezicht I; Paris M; Nassar M; Baltodano A; Rogers J; Sáez-Llorens X; Olsen KD; McCracken GH
    N Engl J Med; 1991 May; 324(22):1525-31. PubMed ID: 2027357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of antimicrobial drugs in the cerebrospinal fluid.
    Skopnik H; Heimann G
    Pediatr Pharmacol (New York); 1983; 3(3-4):313-20. PubMed ID: 6330656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment with a cefotaxime-fosfomycin combination of staphylococcal or enterobacterial meningitis in adults].
    Portier H; Armengaud M; Becq-Giraudon B; Bousser J; Desbordes JM; Duez JM; Kazmierczak A; Korinek AM; Laisne MJ; Pangon B
    Presse Med; 1987 Dec; 16(43):2161-6. PubMed ID: 2963304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Penetration of ceftizoxime (FK 749) into the cerebrospinal fluid (author's transl)].
    Ruf B
    Infection; 1982; 10(2):76-80. PubMed ID: 6284650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and clinical evaluation of cefotaxime in children suffering with purulent meningitis.
    Bégué P; Floret D; Mallet E; Raynaud EJ; Safran C; Sarlangues J; Teyssier G
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():161-5. PubMed ID: 6094436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penetration of Cefotaxime into Cerebrospinal Fluid in Neonates and Young Infants.
    Chen XK; Shi HY; Leroux S; Xu HY; Zhou Y; Zheng Y; Huang X; Li Y; Jacqz-Aigrain E; Zhao W
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of cefotaxime in gram-negative meningitis.
    LeFrock JL; Molavi A; Smith B; Black P; Rosenberg M; Rolston K; Brodner R; Chandrasekar P; Henao L; Kannangara DW
    Neurosurgery; 1984 Nov; 15(5):679-82. PubMed ID: 6095133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefotaxime levels in ventricular cerebrospinal fluid, determined by bioassay and by high-performance liquid chromatography.
    Brückner O; Collmann H; Borner K
    Chemotherapy; 1983; 29(4):237-43. PubMed ID: 6307602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
    Kim KS; Manocchio M; Bayer AS
    Chemotherapy; 1984; 30(4):262-9. PubMed ID: 6086247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges.
    Nau R; Prange HW; Muth P; Mahr G; Menck S; Kolenda H; Sörgel F
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1518-24. PubMed ID: 8363385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis.
    Martin E; Koup JR; Paravicini U; Stoeckel K
    J Pediatr; 1984 Sep; 105(3):475-81. PubMed ID: 6088747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefotaxime treatment of gram-negative enteric meningitis in infants and children.
    Jacobs RF
    Drugs; 1988; 35 Suppl 2():185-9. PubMed ID: 3293975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of cefotaxime in gram-negative bacterial meningitis. Apropos of 3 developmental forms in neonates and infants].
    Sarlangue J; Megraud F; Nelson JR; Martin C
    Pediatrie; 1984 Dec; 39(8):645-51. PubMed ID: 6100207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children.
    Barson WJ; Miller MA; Brady MT; Powell DA
    Pediatr Infect Dis; 1985; 4(4):362-8. PubMed ID: 3895175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
    Reed MD; Rekate HL; Aronoff SC; Myers CM; Blumer JL
    Clin Pharm; 1983; 2(6):558-63. PubMed ID: 6317277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.